View Press Releases
-
PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System
PathAI, a global leader in AI-powered digital pathology solutions and the developer of the market-leading AISight1 Image Management System (IMS), today announced the integration of several AI products from market leading digital pathology companies, including Deep Bio, DoMore Diagnostics, Paige, and Visiopharm. Through these collaborations, PathAI will provide algorithms from these developers directly within its AISight IMS, reinforcing its commitment to offering the most versatile, reliable, and interoperable IMS on the market.
Nov 18, 2024
-
Endor Labs Collaborates with Microsoft Defender for Cloud to Create Industry’s First Code-to-Runtime Reachability in a CNAPP
Endor Labs today announced that Microsoft has natively integrated its Software Composition Analysis (SCA) solution into Defender for Cloud, creating the industry’s first code-to-runtime reachability in a Cloud-Native Application Protection Platform (CNAPP). The integration empowers organizations to consolidate their application security and cloud security programs into a single platform, securing cloud workloads and code in one place. They can deploy SCA and CNAPP solutions from a unified dashboard, and achieve comprehensive security coverage from code to runtime.
Nov 18, 2024
-
Illumina Rolls out MiSeq i100 Series to Reshape Next-Generation Sequencing
The MiSeq i100 Series of sequencing equipment was introduced by Illumina, a multinational corporation dedicated to DNA sequencing and array-based technologies. The new systems are designed to improve next-generation sequencing (NGS) capabilities for labs by providing quick turnaround and user-friendliness.
Nov 19, 2024
-
Sapio Sciences Collaborates with Waters Corporation to Improve Efficiency of Laboratory Operations
Sapio Sciences, the science-aware™ lab informatics platform, today announced it has entered a co-marketing agreement with Waters Corporation to enhance data integrity, workflow efficiency, and laboratory productivity
Nov 17, 2024
-
Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients
Owkin’s MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of Proscia’s precision medicine AI portfolio.
Nov 18, 2024
-
Future Fields Debuts Instar 1.0: A Biofactory With 30 Times the Output of Conventional Protein Technology
Recombinant protein biomanufacturer debuts factory and new product line
Nov 17, 2024
-
Oregon Freeze Dry Brings in New Leadership
Life Sciences CDMO Veteran David Enloe Appointed CEO of OFD.
Nov 17, 2024
-
Cotiviti to Launch End-to-End Healthcare Fraud Solution at 2024 NHCAA Annual Training Conference
-
Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses
Sakura Finetek Europe and MEDIPATH announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management.
Nov 18, 2024
-
City Therapeutics Debuts with $135M Series A to Revolutionize RNAi-Based Therapeutics
City Therapeutics, which uses next-generation engineering of small interfering RNAs (siRNAs) to drive improvements in RNA interference (RNAi)--based therapeutics, has announced its debut along with a $135 million Series A funding.
Nov 17, 2024
-
Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer
Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.
Nov 13, 2024
-
Introducing FlexFactory to Poland, delivered by Cytiva and operated by SyVento Biotech
-
2BScientific limited announces opening of a new European hub in Germany
2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing European markets. The hub will also enable the company to enter new supplier partnerships, enhancing the range of products available to its European customers and broadening the reach of its existing suppliers.
Nov 13, 2024
-
SynbiCITE awarded £3m EPSRC grant to expand engineering biology proof-of-concept programme
SynbiCITE, the U.K.’s National Industrial Translation Centre for Engineering Biology, has been awarded a grant of £3m to expand its Proof-of-Concept (PoC) programme for start-up engineering biology companies.
Nov 13, 2024
-
Kindeva Drug Delivery Appoints New CIO to Lead Digital Transformation Business Initiatives
-
Gifthealth Announces Strategic Partnership with United Digestive
Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.
Nov 11, 2024
-
Oxford Nanopore and Wasatch BioLabs Announce Collaboration to Transform DNA Methylation Analysis with New dWMS Product
The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.
Nov 12, 2024
-
Healthcare Agency Veteran Allison Davis Joins CG Life as Chief Client Officer
CG Life, a leading integrated agency that blends strategy, creative, marketing, digital, and communications with science, has welcomed Allison Davis to the agency’s newly created role of Chief Client Officer.
Nov 11, 2024
-
Ansa Biotechnologies Sets New Standard in Long, Complex DNA
Ansa Biotechnologies just announced that it can deliver its Clonal DNA product in lengths up to 5kb. The longer constructs are made possible due to a new proprietary, sequence-agnostic assembly technology. The complete platform allows Ansa to produce long, complex DNA more accurately and reliably than any other DNA synthesis vendor.
Nov 11, 2024
-
MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance
MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.
Nov 11, 2024